Key facts
- Malama Health’s last known valuation is $21.5M (Mar 2026).
- It has raised $9.8M across 1 recorded rounds; the latest was Early Stage VC ($5.3M) in Feb 2026.
- Notable investors include Y Combinator, MassChallenge, National Institutes of Health, Samsung NEXT Ventures, Matter (Consulting Services (B2B)) — 17 tracked in total.
- Malama Health has filed 1 Form D with the SEC, most recently Feb 2026 ($5.3M sold to 15 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Malama Health
Funding rounds
1 roundsAbout Malama Health
Developer of a personalized support platform designed to improve the management of diabetes in pregnancy. The company's platform offers a glucose and meal level tracker, helps identify food triggers and trends, and provides access to one-on-one coaching to optimize health through pregnancy, enabling patients to access actionable insights to maximize health through pregnancy and beyond.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 15
- Website
- heymalama.co/
- Ownership
- Privately Held (backing)
Malama Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Malama Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Malama Health in its N-PORT filings yet. We sweep new filings monthly.